LIQUID PHARMACEUTICAL COMPOSITIONS

A liquid pharmaceutical composition for use in a pressurized metered dose inhaler (pMDI), which composition comprises a pharmaceutically acceptable addition salt of (i) carcainium, and (ii) sulfuric acid, hydrochloric acid, hydrobromic acid, maleic acid or 1-hydroxy-2-naphthoic acid(xinafoic acid)....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CHOI, LEWIS SIU LEUNG, PLOUVIER, BERTRAND MICHEL CLAUDE, NORTHEN, JULIAN SCOTT, SPARGO, PETER LIONEL, FRENCH, EDWARD JAMES
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A liquid pharmaceutical composition for use in a pressurized metered dose inhaler (pMDI), which composition comprises a pharmaceutically acceptable addition salt of (i) carcainium, and (ii) sulfuric acid, hydrochloric acid, hydrobromic acid, maleic acid or 1-hydroxy-2-naphthoic acid(xinafoic acid). L'invention concerne une composition pharmaceutique liquide destinée à être utilisée dans un inhalateur doseur pressurisé (IDP), la composition comprenant un sel d'addition pharmaceutiquement acceptable de (i) carcaïnium et de (ii) acide sulfurique, acide chlorhydrique, acide bromhydrique, acide maléique ou acide 1-hydroxy-2-naphtoïque (acide xinafoïque).